MedTrace Logo

Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)

NCT04989543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2021-12-14

No results posted yet for this study

Summary

It aims to determine and compare the degree of vaginal bacterial alpha diversity in the absence (healthy population) or presence of bacterial vaginosis (pathological population).

Conditions

  • Vaginosis, Bacterial

Interventions

DIAGNOSTIC_TEST

vaginal swabs

Nugent score: Vaginal swabbing with the dry swab, make two smears on slides. Cytobacteriological examination: swabbing at the exo-endocrine junction using the swab Evaluation of the vaginal microbiota: swabbing at the exo-endocrine junction using the swab

Sponsors & Collaborators

  • CEN Biotech

    collaborator INDUSTRY

  • Luxia Scientific

    collaborator INDUSTRY

  • Larena SAS

    lead INDUSTRY

Principal Investigators

  • Samira AIT ABDELLAH · Larena SAS

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-24
Primary Completion
2020-12-03
Completion
2021-11-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04989543 on ClinicalTrials.gov